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The gene encoding the receptor for macrophage colony-stimulating factor 1 (CSF-1), the c-fins proto-
oncogene, is selectively expressed in immature and mature mononuclear phagocytes and trophoblasts. Exon 1
is expressed only in trophoblasts. Isolation and sequencing of genomic DNA flanking exon 2 of the murine c-ins
gene revealed a TATA-less promoter with significant homology to human c-Jins. Reverse transcriptase primer
extension analysis using exon 2 primers identified multiple clustered transcription initiation sites. Their position
was confirmed by RNase protection. The same primer extension products were detected in equal abundance
from macrophage or nonmacrophage sources of RNA. c-Jins mRNA is acutely down-regulated in primary
macrophages by CSF-1, bacterial lipopolysaccharide (LPS), and phorbol myristate acetate (PMA). Each of
these agents reduced the abundance of c-fns RNA detectable by primer extension using an exon 3 primer
without altering the abundance of presumptive short c-Jins transcripts detected with exon 2 primers. Primer
extension analysis with an intron 2 primer detected products at greater abundance in nonmacrophages.
Templates detected with the intronic primer were induced in macrophages by LPS, PMA, and CSF-1,
suggesting that each of the agents caused a shift from full-length c-Jins mRNA production to production of
unspliced, truncated transcripts. The c-Jins promoter functioned constitutively in the RAW264 macrophage cell
line, the B-cell line MOPC.31C, and several nonhematopoietic cell lines. Macrophage-specific expression and
responsiveness to selective repression by LPS and PMA was achieved by the incorporation of intron 2 into the
c-Jins promoter-reporter construct. The results suggest that expression of the c-fins gene in macrophages is
controlled by sequences in intron 2 that act by regulating transcription elongation.
Macrophage colony-stimulating factor 1 (CSF-1) promotes
the survival, proliferation, and differentiation of cells of the
mononuclear phagocyte series (29). Its biological activities
are mediated by binding to a plasma membrane receptor, the
product of the c-fins proto-oncogene, which is a ligand-
dependent protein tyrosine kinase (24). Expression of c-fins
mRNA and CSF-1 binding activity is largely restricted to
mononuclear phagocytes and placental trophoblasts (24).
Although there has been considerable progress in under-
standing tissue-specific gene expression in other hematopoi-
etic cell lineages, macrophage differentiation remains poorly
understood at the level of gene transcription. The most
extensive studies have been of the lysozyme gene in chick-
ens, which is controlled by a complex interaction between
macrophage-specific enhancer elements and silencers that
restrict gene expression in nonmacrophages (10). The pau-
city of information about macrophage-specific gene expres-
sion has been attributed to the difficulty of obtaining high
transfection efficiencies with primary mammalian macro-
phages or myelomonocytic cell lines (25), a technical obsta-
cle that we have recently overcome in a study of the
constitutive elements controlling the expression of the uroki-
nase plasminogen activator gene in macrophages (3). The
limited literature on macrophage-specific gene expression
has been largely dependent upon the use of transgenic
animals (2, 25), which places limitations on detailed analysis
of cis-acting sequences. Preliminary characterization of the
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human gene encoding c-fins revealed that in the two cell
types that express the gene, trophoblasts and macrophages,
transcription is initiated from two separate promoters, sep-
arated by a 25-kb intron (30). A limited analysis of transcrip-
tional regulation of the two promoters in human cell lines
(20) suggested that a 550-bp segment flanking exon 2 can
direct macrophage-specific expression of a reporter gene. In
this report, we show that the murine c-fins gene contains a
constitutive promoter and that production of full-length
mRNA is controlled by sequences in intron 2 that regulate
transcript elongation.
MATERUILS AND METHODS
Cell lines and cell culture. The cell lines RAW264, Lewis
lung carcinoma (LLC1 or LL/2), L929 (fibrosarcoma),
BALB/3T12-3 (embryonic fibroblasts), BALB/c 10ME
HD.A 5R.1 (methylcholanthrene-transformed fibroblasts),
BALB/c Cl.7 (embryonic fibroblasts), and MOPC.31C were
obtained from the American Type Culture Collection. They
were maintained in RPMI 1640 plus 10% fetal bovine serum.
Primary bone marrow-derived macrophages (BMDM) were
produced by cultivation of murine femoral bone marrow
cells in recombinant human CSF-1 (a gift from Chiron Corp.)
as described previously (14, 15). Lipopolysaccharide (LPS;
Re595 from Salmonella minnesota) and phorbol myristate
acetate (PMA) were obtained from Sigma.
Mouse c-fins genomic clone isolation and plasmid construc-
tion. A mouse genomic DNA library from the A17 murine
T-cell lymphoma cell line in XEMBL3A (a gift from Mark
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Hogarth) was screened with a 5' restriction fragment of the
murine c-fins cDNA (21) kindly provided by Larry Rohr-
schneider. A clone containing a 14-kb Sall insert was iso-
lated, the restriction map of which was consistent with the
identity of this clone as the Sall genomic DNA fragment
which encompasses the 5' end of the murine c-fins gene (9).
A 7-kb ApaI fragment bracketing the 5' end of the gene was
subcloned into pBluescript (Stratagene) to yield pXYfinsl,
and subfragments were sequenced by the dideoxy-chain
termination method, using a Pharmacia T7 polymerase kit
and double-stranded plasmid templates. The 3' ApaI site in
this clone is at position 134 in the murine cDNA sequence
(21). The restriction map of this fragment is presented in Fig.
7, in the context of the analysis of reporter constructs.
Chloramphenicol acetyltransferase (CAT) reporter con-
structs were generated by subcloning the desired restriction
fragments from the ApaI genomic DNA fragment in pBlue-
script into the multiple cloning site of the vector pCAT-Basic
(Promega). The positive control vector pH,BAPr-CAT, a gift
from Peter Gunning, contains a 4.3-kb EcoRI-AluI fragment
of the human P-actin promoter linked to the CAT gene. An
additional set of reporter constructs was constructed in the
luciferase reporter gene plasmid pGL2-Basic (Promega).
This vector has the advantage of both increased sensitivity
and a low nonspecific background due to the presence of a
polyadenylation signal, to prevent read-through transcripts
from the vector, placed upstream of the multiple cloning site.
The desired restriction fragments from the ApaI genomic
DNA clone were also cloned into the multiple cloning site of
this vector. In the case of the intron-containing c-fins plas-
mid, pGL6.7flns, the c-fins genomic DNA was removed
from pXYflnsl as an SpeI fragment and inserted into the
same site in pGL2-Basic. The 5' SpeI site in this case is
approximately 50 bp into the c-fins promoter sequence,
while the 3' SpeI site is in the pBluescript multiple cloning
site. Plasmid pGL2-Control, containing the simian virus 40
(SV40) early promoter and enhancer, was used in some
experiments. Because this vector displayed some apparent
tissue specificity, another control vector was produced by
inserting the EcoRI-AluI fragment of the human ,B-actin
promoter (see above) into the multiple cloning site of pGL2-
Basic. This plasmid is referred to as pGL-HPAPr.
RNA extraction, RNase protection, and primer extension
analysis. RNA was isolated by the method of Evans et al. (8).
Briefly, cells were lysed by shearing in 8 M guanidine-HCl-
0.3 M sodium acetate-1% sarcosyl. After centrifugation, the
supernatant was ethanol precipitated, and the pellet was
suspended in 8 M guanidine-0.3 M sodium acetate, repre-
cipitated, washed twice with 70% ethanol, and dissolved in
Tri§-EDTA buffer. Primer extension was performed exactly
as described by Sambrook et al. (22) except that N-2-
hydrdxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES)
buffer was substituted for piperazine-N,N'-bis(2-ethane-
sulfonic acid) (PIPES). Superscript RNase H- Moloney
murine leukemia virus reverse transcriptase was obtained
from Bethesda Research Laboratories. The following prim-
ers were used (their positions in the c-fins gene are described
in Results): primer A, 5'-TTGGAGAGTCGGCTGGGCACG
GGGCTCCCAGCTGCTAGTTCT; primer B, 5'-ATGCCA
AACTGTGGCCAGCAGCAGGACCAGAGGAGGCCCC;
primer E, 5'-CCAGTTCTGGGCCACTAGGCTCGATGA
CAGGGGCCCCCTGACCATG; and primer F, 5'-GAGGCA
TCACATGCAGGACAGCGATGCCCTCTTTTGCAACACT
CCCCC.
At the end of the reaction, 20 Rl of 1 M NaOH was added
to the 30-,l incubation, and the RNA template was hydro-
lyzed for 15 min at 65°C before neutralization with 20 VI of 1
M HCl plus 20 pA of 1 M Tris-HCl (pH 7.6). The transcribed
DNA was recovered by ethanol precipitation and separated
by electrophoresis on 6% polyacrylamide-8 M urea sequenc-
ing gels in parallel with a sequencing ladder generated by
using the same primer and lpxyfmsl as a template.
For RNase protection assays, a 410-bp c-fins genomic
DNA fragment (XbaI [-203] to SmaI [+207]) or a 200-bp 5'
cDNA fragment (EcoRI in the host vector to BstEII at bp 186
[21]) was cloned into pBluescript. A 32P-labeled antisense
RNA probe was synthesized by using T3 RNA polymerase.
For dot blot hybridization, a sense probe was also synthe-
sized by using T7 RNA polymerase and treated identically.
The reaction mixture contained 2 ,ug of template DNA in 100
,ul of reaction buffer (40 mM Tris-HCl [pH 7.61, 6 mM
MgCl2, 2 mM spermidine, 5 mM NaCl, 10 mM dithiothreitol,
200 ,ug of bovine serum albumin per ml, 500 ,uM ATP, CTP,
and GTP, 25 ,uM tJTP, 10 ,ul of [a-32P]UTP [10 ,uCi; 800
Ci/mmol; New England Nuclear]). The reaction was termi-
nated by addition of DNase I, the products were separated
on 5% polyacrylamide gels, and the labeled probe band was
excised and eluted overnight in 50% deionized formamide.
The probe (50,000 cpm) was added to 10 ,ug of DNase
I-treated RNA, precipitated in 70% ethanol, and redissolved
in 20 ,u of 4 mM HEPES (pH 6.4)-0.1 mM EDTA-40 mM
HCI-80% deionized formamide. After heating to 85°C for 15
min, the mixture was cooled to 45°C and allowed to hybrid-
ize overnight. Then 350 ,ul of RNase buffer (10 mM Tris-HCl
[pH 7.5], 5 mM EDTA, 300 mM NaCl, 0.4 ,ug of RNase T1,
8 per ml, ,ug of RNase A per ml) was added, and the mixture
was incubated for 30 min at 37°C. The reaction was stopped
by addition of 20 VI of 10% sodium dodecyl sulfate (SDS)
plus proteinase K (final concentration, 12.5 ,ug/ml) and
incubation for 30 min. Following phenol-chloroform extrac-
tion and ethanol precipitation in the presence of 20 ,ug of
tRNA, the protected bands were separated on 8% polyacryl-
amide sequencing gels.
Transient transfection. Transient transfections and CAT
assays were carried out as previously described (3). Briefly,
5 x 106 cells in 250 ,u were transfected by electroporation at
750 V/cm (0.4-cm cuvettes) and 960-,uF capacitance in RPMI
1640-10% fetal calf serum at room temperature and returned
immediately to culture at 37°C. After 24 h for luciferase or 48
h for CAT assays, cells were harvested and assayed for
reporter gene activity. The luciferase activity was assayed
by using reagents supplied by Promega and measured with a
Berthold luminometer. Activities were normalized to cell
protein assayed by using a Bradford microprotein assay with
reagents supplied by Bio-Rad.
RESULTS
c-fins promoter sequence. Figure 1 shows the DNA se-
quence of the mouse and human c-Jins genes flanking exon 2.
Because of the heterogeneous transcription initiation sites
identified below, the two sequences are numbered relative to
the initiation codon. Between -160 and -110, the alignment
is tenuous, as both species have an extended polypurine
tract which in the mouse includes 24 consecutive A residues.
The alignment between the two species is also interrupted
around -250 by the insertion in the mouse of a short GT
repeat that is absent from the human gene. Beyond the
conserved region shown, there is no obvious homology
between the next 250 bp of mouse sequence and 600 bp of
human sequence (not shown). In this region, the human gene
contains anAlu repeat (20). The most conserved parts of the
MOL. CELL. BIOL.
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-497M AAGGGCAGAT GAGAAA..GG TATG.AAGAA TGTAGGATAA
-485H CAGGGTAAAG AAAAAATAAA TATGTCACAA TATCATGCAA
AP2
-460M CCTGACCTCT C TC AGCCAGGCTC A.CTGCTCA.
-445 H CCTAACTTCT CTTTGGGATC TGCCAGAGCC ACCTGATCAC
TATA (SV-40) APi
-429M TCTGGGAGAC TCTTATTTAT GCTCCTGACT CAGAGGCTG.
-405H TCTG.AAGAC CCTCATTTGT GCTACTGACT AACGGTCTGG
AP2 AP1 PU-ets
-39gM CTGCTCTTGG GATATGACTC CTCTCCTAAG TGTCCTTAGA
-366H CTGCTCTTGG .ACATGTCTC TTCTCCCAAG ACCCCTTGAA
GTIbox Pp CCAAT/GT.box p
-350M GGTGGTTTCC TAAG TCTCTC AAACTCCATC ATCTCCCTTC
-327H GATGGCTTTA GAAGGGCCCC AAACTTAGCT AGCTCCCCCC
-310M AGGATCAGTT GAGCCTGGCC CCAGATTCTG CCTCTTCCTC
-287H AAGCTCAGGC TGGCCCTGCC CCAGACTGCG ACCCCTCCCT
GT-box
-270M TGGTGTGTGG TGTGTGTGTG TGTGTGTGTG TGTGTGTGTG
-247H CTTGGGTTCAA .......... ..........
fl, PU-o_
-230M TGTGTATGTG TGTGTGCTTT GTTTTCTTCT AGAGACCCAA
-235H GCTTT GTTTTCTTCT AAAGACCCAA
CCAAT/GT-box PU-et
-190M TATTTCCAAA TTCTGTAGTT CCCTTTCAGG CAACCTAAAA
-210H GATTTCCAAA CTCTGTGGTT GCCTTGCCTA GCTAAAAGGG
-150M AAAAAAAAAA
-170H GAAGAAGAGG
-120M ..AG
-130H AGACAAACAG
PU-os
AAAAAAAAAA GGGGAAGAGG
ATCAGCCCAA GGAGGAGGAA
Ft PU-ew
CCAGTGCAAC AGACAGGAAC
CCAGTGCAGA GGAGAGGAAC
-89M TGTTCCCG.T CCTCACAGAA CTAGCAGCTG
-9gH TGT.CCCGAT CCCAGCGGAG CTAGTAGCTG
-50M GCCCAGCCGA
-51 H TCCTGGGCAC
GAGGAAAACA
Fl,F" F"
GTGT TCATC.
GTGT GTCCAG
GG AG C C CCG T
AG AG C TC TG T
CTCTCCAACC TGCATCGGCT CACGCTATCC
CTTGCAGCCC TGCACCTGCC TGCCACTTCC
-1 M CCTG GAGGC TflT0JGAG
-uuH CCACCGAGGC CIA T GGC
FIG. 1. DNA sequence of the proximal promoter of r1iurine
c-fins. The sequence of the human gene is derived from reference
20. Alignment between the two species was ascertained by using
MacVector software. Arrows mark major transcription start sites in
the two species, and numbering is shown relative to the first base of
the initiation codon. Putative binding sites for known transcription
factors are indicated and discussed in the text.
c-fins promoters of the mouse and human genes contain
several sites similar to the binding sites of the ubiquitous
CCAAT box-binding proteins (Fig. 1), but none fits perfectly
the consensus sequence for CBP-1, CBP-2, or NF-1 (6). The
c-fns promoters in both species contain multiple polypurine
and polypyrimidine strings containing the 5'-GGAA-3' rec-
ognition site of the ets family of transcription factors (31),
including two copies in each species of the PU box (5'-
GAGGAA-3'), the binding site for the transcription factor
PU.1, which is restricted to B cells and macrophages (17).
One other feature of interest is the multiple APl-like (5'-
TGACTCA-3') and AP2-like (5'-CCCAGGC-3') sites in both
species, both of which might confer phorbol ester respon-
siveness (5). Finally, the murine c-Jins promoter contains the
TATA-like sequence 5'-TTATTTfATGC-3' at -252 (Fig. 1),
but this sequence does not appear to be conserved in the
human gene.
Reverse transcriptase primer extension and RNase protec-
tion analysis of c-Jins mRNA in macrophages and nonmac-
rophages. To determine the transcription start site of the
mouse c-fins promoter flanking exon 2, we performed re-
verse transcriptase primer extension analysis using DNase
I-treated RNA from murine BMDM (Fig. 2). Primer exten-
sion using a 40-bp oligonucleotide (primer A) complemen-
tary to the 5' end of the reported murine cDNA sequence
(-75 in Fig. 1) (21) revealed numerous candidate transcrip-
tion start sites (Fig. 2A). No bands were observed when
nucleotides were omitted from the reverse transcriptase
reaction (Fig. 2A) or when tRNA was used as a template (not
shown). The major candidate transcription start sites are
indicated in Fig. 1. While some of them correlate exactly
with those identified in human monocyte-like cells (20),
others extend further upstream. The same pattern of tran-
scription start sites was observed when RNA from the
macrophage cell line RAW264 was used (Fig. 2A). Surpris-
ingly, identical primer extension products at comparable
abundance were also produced with use of RNA from
nonmacrophage cell lines such as the B-lymphocyte cell line
MOPC.31C (Fig. 2A). To eliminate the possibility of artifact,
the primer extension was repeated with use of a second
40-bp oligonucleotide (primer B) which hybridized to the end
of the second exon, approximately 80 bp 3' of primer A.
Again, the same products at comparable abundance were
obtained with use of RNA from primary macrophages,
RAW264 cells, and MOPC.31C B cells (Fig. 2B). Evidence
for this lack of specificity was extended to nonhematopoietic
cells, L929 fibrosarcoma (Fig. 2B) and Lewis lung carcinoma
(not shown). Finally, when primer E, complementary to the
5' end of exon 3, was used, extension products were
generated from primary macrophage or RAW264 RNA (Fig.
2C) but not from MOPC.31C, Lewis lung carcinoma (Fig.
2C), or L929 (not shown) RNA. This finding suggested that
c-fins transcripts are initiated in nonmacrophages but termi-
nate before the beginning of exon 3.
c-fins mRNA is down-regulated in macrophages by the
ligand, CSF-1, and by bacterial LPS and phorbol esters
(PMA) (11, 23). The actions of LPS are associated with
cessation of c-fins-specific transcription in nuclear run-on
transcription assays (11). We confirmed that each of these
agonists down-regulated c-fins mRNA in BMDM and
RAW264 cells by Northern (RNA) analysis (data not shown,
but see also Fig. 6). Figure 3 shows the result of primer
extension analysis with RNA from BMDM starved of CSF-1
(which maximally up-regulates c-fins mRNA) and then
treated with CSF-1, LPS, or PMA. Using the exon 2 primer
(primer B), no effect of CSF-1, LPS, or PMA on the yield of
primer extension products was observed. Conversely, when
primer E (at the beginning of exon 3) was used, there was a
clear decrease in the yield of all of the extension products in
response to each of the three agonists. The magnitude of this
decrease is indicated by quantitation of the total radioactiv-
ity incorporated into extension products with use of an
AMBIS Radioanalyser (Fig. 3). The same pattern of results
was obtained with use of the three stimuli on RAW264 cells
(not shown).
If there is a block to transcription elongation prior to the
beginning of exon 3 in nonmacrophages and in macrophages
treated with agonists, it should be possible to detect tran-
scripts containing intron 2. To investigate this possibility,
the sequence of the mouse gene early in intron 2 was
ascertained. Sequencing of this region was particularly dif-
ficult because of extensive secondary structure which was
not resolved by using Taq polymerase at higher temperature.
Readable sequence required the use of deaza-dGTP and 8 M
urea-30% formaldehyde denaturing gels. Alignment of the
mouse and human sequences in this region reveals low-level
homology (Fig. 4). Regions of transcription attenuation in
eukaryotic genes have commonly been associated with GC-
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FIG. 2. Primer extension analysis of sites of c-fms transcription initiation. RNA from the cell lines indicated was annealed with
radiolabeled primer A (which extends to the end of the published murine c-Jins cDNA sequence) (A), primer B (which hybridizes to the end
of exon 2) (B), or primer E (which hybridizes to the beginning of exon 3) (C), incubated with reverse transcriptase and deoxynucleotides, and
separated on a polyacrylamide gel in parallel with a sequencing ladder derived by using the same primer and double-stranded c-fins genomic
DNA in pBluescript as a template. In control reactions, deoxynucleotides were omitted.
rich elements containing dyad symmetry which might poten-
tially form stable stem-loops in transcribed RNA or single-
stranded DNA (27). The intronic sequences of both the
mouse and human c-fins genes contain extended GC-rich
repeats. Potential stem-loops formed by these repeats are
shown in Fig. 4 and compared with the TAR region of the
human immunodeficiency virus, a known stable secondary
structure (27).
Primer extension was repeated by using a primer (primer
F) based upon the intron 2 sequence around the predicted
stem loop in Fig. 4. Identical primer extension products were
detected in all cell types examined, except BMDM starved
of CSF-1 to maximally up-regulate c-fins mRNA (Fig. 5). In
these cells, the level of intron-containing RNA was much
lower but was increased by each of the agonists, LPS, PMA,
and CSF-1, shown to down-regulate full length c-fns mRNA
(Fig. 3). The data suggest that the level of intron-containing
transcripts varies inversely with the level of full-length c-fns
transcripts and are consistent with the existence of a site of
selective transcription elongation within intron 2.
In an attempt to identify the sites of transcription attenu-
ation in intron 2 and to independently validate the primer
extension results, we performed RNase protection studies.
c-fins genomic DNA extending from -203 to +210 was
cloned into pBluescript, and a radiolabeled RNA probe was
generated by using T3 RNA polymerase. Both BMDM and
RAW264 RNA protected the labeled probe against RNase
digestion, producing multiple protected bands (Fig. 6A). The
position of these bands relative to the splice donor site at the
end of exon 2 correlated precisely with the clustered tran-
scription start sites identified by primer extension in Fig. 2.
RNA obtained from BMDM treated with CSF-1, LPS, or
PMA was less effective in producing all of the protected
bands, indicating that the abundance of each of the bands
correlates with the abundance of full-length c-fins mRNA.
When RNA from L929, Lewis lung carcinoma, or
MOPC.31C cells was used, no protected bands were de-
tected even when the amount of RNA added was increased
to 50 p,g and the autoradiographs were exposed for a
prolonged period (data not shown).
Because of the extensive GC-rich inverted repeats in exon
2 and the beginning of intron 2, we reasoned that internal
stem loops in the intron-containing truncated transcripts
could be interfering with efficient hybridization. To eliminate
these potential structures from the probe, we prepared a new
probe template by subcloning the 5' end of murine c-fins
cDNA (21) to the BstEII site at bp 186 into pBluescript. With
labeled antisense RNA transcribed from this segment used
MOL. CELL. BIOL.
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FIG. 3. Effects of CSF-1, LPS, and PMA on c-fins transcription
attenuation in BMDM. BMDM were washed and incubated over-
night in the absence of CSF-1 to maximally induced c-fins mRNA.
They were then incubated for 4 h with CSF-1 (1,000 U/ml), LPS (100
ng/ml), or PMA (10-v M) prior to RNA isolation. RNA (50 ,ug) from
each treatment was incubated with radiolabeled primer B (end of
exon 2) or primer E (beginning of exon 3) and extended with reverse
transcriptase. The extension products were separated on a sequenc-
ing gel in parallel with a sequencing reaction. Quantitation was
achieved by scanning the entire gel with an AMBIS Radioanalyser
and counting the total radioactivity in the extension products in each
lane. The results expressed as total counts per minute are displayed
below each lane.
as a probe, RNA from BMDM or RAW264 cells generated
the expected 186-base protected band, but it was still impos-
sible to detect any protected bands when nonmacrophage
RNA was used (data not shown).
The only way to eliminating secondary structures from the
transcripts is to denature and immobilize them. Accordingly,
the 5' c-fins antisense RNA probe was used in a dot blot
hybridization on macrophage and nonmacrophage RNA
bound to nitrocellulose membranes. The result (Fig. 6B)
indicates that macrophages and nonmacrophages do indeed
contain approximately equal levels of transcripts that hy-
bridize to the 5' end of c-fins. Furthermore, as suggested by
the primer extension data in Fig. 3, CSF-1, LPS, and PMA
had no significant effect on the abundance of transcripts
detected with the 5' c-fins probe. The reasons why short
transcripts cannot be detected in nonmacrophages by RNase
protection are considered in Discussion.
A
GGGGAAGAGGAGCCAGTGCAACAGACAGGAACGTGTTCATCTGTTCCCGTCCTCACAGAA
AACTAGCAGCTGGGAGCCCCGTGCCCAGCCGACTCTCCAACCTGCATCGGCTCACGCTAT
CCCCTGGACTFTAGTTGGGGCCTCCTCTGGTCCTGCTGCTGGCCACAGTTTGGCAT
-------
0
Human GGTAAGAGCAGAACGGGGGGTGGGGACTTTGTTGGGGTGTGATGGAGAAGACCC
House GGTAAGGGGAGAAAAGGGGAG TCTGCTGGGGGAGTGTTGCAAAGAGGG
a
Human CTGTGAAAGGATTCAGTCCTTGCCCCTCACTGGGTGTCCTCAGGCTGTTTTAGT
House CATCGCTGTCCTGCATGTAGATG CCTCATTCTCTGCTTCA
.
Human CTCCCCAA CACTGGACTGCAGGCTTGTGGGTATCTGCTTTTGGAGAGGTAGTG
Mouse CTTCTCTGGCATAATATTGCAGATTTGTGTTTATCTG TCGAGAAGAGGTAGTG
a
Human GGGTGAAAAGAGATGGGTGTGGTGGAACTGGTCCACCTGGTGCTGTGGATCTGT
House TGAGAGTGGTGGTTCCACCCTGAGCCAGTCTGTGGAGTGTGTCTGT
a A A G
C G
a T C A A T
AGGGGAGAAAAGGGGAG TGGGGGAGTGTTGCA GGGCA C
: .:.: : :.:: : .:: ... *:: A*.. ...
TCTCTTCACTTCCTCTC TT ACTCCGTAGTGACGT CCTGT
a T c
0 TGA
TGTTGGGGTG TGGAGACCCCTGTGA AAGGAT T
ACAACCCCCC ACTCCTGGGGTCACT TTCCT A
AG C G GT G c c
T C
TG
C
c T T C T
GGT TCTCTGGTTAGACCAGA GAGC T
CCA AGGGATCAATC GGTCT CTCG cAG
mouse stem
loop
hulman stem loop
RIV TAR stem loop
FIG. 4. Sequence analysis of the second intron of murine c-fins.
(A) Sequence of murine c-fins. New sequence starts at the splice site
indicated by an arrow, which is in the identical position of the
human gene. Significant alignment with the human c-fins genomic
sequence obtained from EMBL (accession number X14720) was
determined by using MacVector software. Both species contain a
long inverted repeat between the bases indicated by the squares
(mouse) and circles (human). These sequences have the potential to
form stable stem-loops in transcribed RNA or single-stranded DNA
as indicated in panel B. The stem-loop structure formed by the
human immunodeficiency virus (HIV) TAR region is shown for
comparison (see Discussion).
Transient transfection analysis. The expression of similar
levels of presumptive short c-fins transcripts in macrophages
and nonmacrophages implies that the c-fins promoter is not
tissue specific. Promoter specificity was assayed directly by
transient transfection using reporter gene constructs linking
the CAT gene to the c-fins promoter. Because of the
heterogeneity of transcription start sites identified in Fig. 2,
most of the constructs were designed to include the entire 5'
untranslated region of c-fins by retaining the c-fins initiation
codon. In the first experiment, a series of CAT reporter
construct deletions was transfected into RAW264 cells. The
most extensive construct contained ca. 3.5 kb of 5' flanking
sequence. Sequential deletion of the 5' flanking sequence
produced little alteration of the level of reporter gene ex-
pression (Fig. 7a). Even deletion to -200 reduced but did not
abolish the constitutive activity in RAW264 cells. 3' trunca-
tion of the promoter to -63 (Fig. 1) (which means that the
CAT rather than the c-fins initiation codon is used) also had
little effect. This construct is comparable to the human c-fins
promoter constructs used by Roberts et al. (20) in which the
_ ... .... . ..... . -
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FIG. 5. Detection of RNA containing sequences homologous to
c-fins intron 2 by reverse transcriptase primer extension. DNase-
treated RNA was prepared from each of the cell lines indicated and
from BMDM treated with CSF-1, LPS, or PMA as indicated in the
legend to Fig. 3. RNA (50 p.g) was hybridized to radiolabeled primer
F, which is based upon the sequence in the vicinity of the potential
stem-loop early in murine c-fins intron 2 (Fig. 4), and extended by
using reverse transcriptase. The extension products were separated
on a sequencing gel in parallel with a sequencing ladder generated by
using the same primer. Quantitation was achieved by scanning the
entire gel with an AMBIS Radioanalyser and counting the total
radioactivity in the extension products in each lane. The results
(expressed as total counts per minute) are displayed below each
lane.
CAT gene was fused at -57. Treatment of the RAW264 cells
transfected with the reporter constructs with PMA had no
effect on CAT activity (Fig. 7a). The activities of long
(pFMS3.5CAT) and short (pFMSO.3CAT) c-fins reporter
constructs were also tested in nonmacrophages, using a
,-actin promoter-CAT construct as a transfection control.
The relative activities of the two c-fins constructs did not
distinguish RAW264 cells from the B-cell line MOPC.31C or
any of the nonhematopoietic murine tumor cell lines tested
(Fig. 8).
To address the role of intron 2 in generating tissue
specificity, the c-fins genomic DNA fragments were trans-
ferred to the luciferase reporter construct, pGL2-Basic.
Apart from the availability of a more convenient set of
A
Probe
B
RADIOACTIVITY RATIO
CELL LINES (ANTISENSE PROBE /SENSE PROBE)
BMDM 5.3
BMDM.CSF-1 4.4
BMDM+LPS 3.7
BMDM+PMA 5.6
RAW264 4.1
RAW264-iCSF- 6.1
RAW264i LPS 4 1
RAW264i.PMA 11.4
Lewis Lung Carc noril.a 5.3
L929 8.6
MOPC 31C l 4.1
FIG. 6. (A) RNase protection analysis of the 5' ends of c-fins
transcripts expressed in macrophages. RNase protection was carried
out as described in Materials and Methods. The RNA samples derived
from BMDM treated with various agonists or from RAW264 cells are
the same as those shown in Fig. 3. Shown are the protected bands
separated on an 8% polyacrylamide sequencing gel, with the position
of the undigested 420-base probe (run on a separate lane on the gel)
indicated by the arrow. The size of each protected band was ascer-
tained by comparison with a sequencing ladder run in parallel. Under
precisely the same conditions, RNA from MOPC.31C, L929, or Lewis
lung carcinoma cells failed to protect the probe from digestion (not
shown). (B) Detection of short c-fins transcripts by RNA dot blot
hybridization. Total RNA (10 ,ug) from the cell lines indicated was
dissolved in 50% formamide-8% formaldehyde-1 x SSC (0.15 M NaCl
plus 0.015 M sodium citrate), heated to 68'C for 15 min, transferred to
Hybond N (Amersham) membranes under vacuum, washed with 10 x
SSC, and then baked overnight at 80°C. The treatments of the BMDM
and RAW264 cells are the same as in Fig. 3 and 5. Duplicate blots were
hybridized with either 32P-labeled antisense or sense RNA homologous
to the 5' end of c-fins to cDNA bp 186 prepared as for RNase
protection (see Materials and Methods). The hybridization was carried
out in 50% formamide-5 x SSC-5x Denhardt's solution-0.1% SDS at
42°C. The blots were washed in 0.1 x SSC-0.1% SDS at 65°C and then
scanned with an AMBIS Radioanalyser. The radioactivity (counts per
minute) present in each dot was counted, and the ratios are presented
as the counts bound with the antisense probe/counts bound with the
sense probe (corrected for the length of the probe).
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FIG. 7. (a) Transient transfection analysis of the activity of the c-fins promoter, using CAT reporter gene constructs. Cells were
transfected with 10 ,ug of reporter plasmid by electroporation (see Materials and Methods), and CAT expression was assayed after 48 h. The
map of the reporter constructs is shown in panel b, and the restriction map of the 7-kbApaI genomic DNA fragment encompassing the 5' end
of the murine c-Jins gene is shown in panel c. Restriction enzyme sites: A, ApaI; S, SacI; P, PvuII; H, HaeIII; X, XbaI; Xh, XhoI; Ev,
EcoRV. In panel a, RAW264 cells were transfected with each of the constructs; then iO-7 M PMA was added to half the cells (shaded bars),
while the remainder were untreated (solid bars). The results are averages of two separate experiments, each of which involved two separate
transfections and separate preparations of plasmid.
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FIG. 8. Comparison of the activities of the short (pFMSO.3CAT)
and long (pFMS3.5CAT) c-fins promoter constructs in macrophages
(RAW264 cells) and a range of nonmacrophage lines with that of the
positive control plasmid pH,3APr-CAT. In each case, the cells were
transfected by electroporation with 10 ,ug of plasmid, and CAT
activity was assayed 48 h later. The results are averages of duplicate
transfections and are representative for each of the cell lines.
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restriction sites in the multiple cloning site, pGL-Basic
provided a much lower negative control than did pCAT-
Basic. Figure 9A compares the activities of three constructs,
a 0.3-kb c-fins promoter, a 3.5-kb c-fins promoter, and a
minigene construct (pGL6.7,fns) containing the 3.5-kb 5'
flanking sequence plus the whole of intron 2 and the begin-
ning of exon 3. The results obtained with the first two
constructs confirm those obtained with the CAT vectors; the
activity of the c-fims promoter relative to the 13-actin pro-
moter did not clearly distinguish macrophages from nonmac-
rophages. The inclusion of the intron 2 sequences reduced
reporter gene expression in RAW264 cells but almost com-
pletely abolished activity in MOPC.31C, L929, and Lewis
lung carcinoma cells. Also shown in Fig. 9A is the compar-
ative activity of the SV40 early promoter and enhancer in the
positive control vector pGL-Control. The 1-actin promoter
was slightly less active in MOPC.31C cells than in RAW264
cells and less again than in L929 and Lewis lung carcinoma
cells. We have confirmed that the levels of 1-actin mRNA
and the rate of transcription of the ,-actin gene in run-on
transcription assays are similar in each cell population (not
shown), so the expression of this construct provides some
indication of transfection efficiency in each case. By con-
trast, pGL-Control (the SV40 early promoter) was 20- to
50-fold more active in MOPC.31C cells than in RAW264
cells, and in L929 and Lewis lung carcinoma cells, it was a
further 10-fold less active. These data suggest that the SV40
enhancer contains tissue-specific cis-acting elements.
The results of the primer extension experiments in Fig. 3
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FIG. 9. Transient transfection analysis of the activity of the murine c-fins promoter, using luciferase promoter constructs. Cells were
transfected by electroporation with 10 ,g of plasmid as described in Materials and Methods. pGLO.3fns and pGL3.5flns contain the same
promoter fragments as do the corresponding CAT vectors in Fig. 7 and 8. pGL6.7fins contains the entire ApaI genomic DNA fragment from
pXTfmnsl, so that the reporter gene is fused into exon 3. It is therefore identical to pGL3.5flns except for the inclusion of intron 2 and exon
3. In each case, cells were returned to medium at 37°C immediately posttransfection and harvested after 24 h for the assay of luciferase
activity. (A) Comparison of the activity of each of the c-fins constructs with the promoterless luciferase parent vector (pGL2-Basic), the SV40
promoter (pGL2-Control), and the ,B-actin promoter (pGL-HPAPr). In some panels, the results from control plasmids are off scale and are
presented in units of 10 RLU as indicated. Note that the activity of pGL6.7fins in the nonmacrophages is not significantly different from the
activity of the promoterless plasmid, pGL2-Basic. The results are averages of duplicate transfections and are representative of three
experiments. (B) Effects of LPS (500 ng/ml), PMA (1 ,ug/ml), and CSF-1 (104 U/ml) added immediately posttransfection on the activity of the
three Jins promoter plasmids. In each case, cells from a single transfection were divided into four wells prior to addition of agonist; results
are averages of two separate transfections. In both of the experiments shown, PMA and LPS induced the activity of the SV40 promoter
construct (pGL2-Control) two- to fivefold but had no effect on the activity of the ,B-actin promoter, while CSF-1 had no effect on the activity
of any promoter. RLU, relative light units.
and 5 suggest that CSF-1, LPS, and PMA reduce c-fis
mRNA levels in macrophages by blocking transcription
elongation within intron 2. Figure 9B shows the effects of the
three agonists on c-fins promoter activity, using the lu-
ciferase reporter constructs above. CSF-1 had no effect in
transient transfections with any of the reporter plasmids,
which may reflect an artifact of transient transfection. In
another study, we showed that the introduction ofDNA into
macrophages prevents them from responding to CSF-1 with
increased growth (28) and prevents induction of the CSF-1-
responsive urokinase plasminogen activator promoter (27a).
By contrast to the data obtained with the CAT reporter
constructs, PMA exerted a slight inhibition of the activity of
the longer (3.5-kb) c-fins promoter but had a far more
marked effect on the activity of the construct containing
intron 2. LPS was more selective; it caused no inhibition of
the activity of the 3.5- or 0.3-kb c-fins promoter but reduced
the activity of the intron-containing construct three- to
fivefold. The effects of the two agents were selective. In
transfections parallel to those shown in Fig. 9, the SV40
promoter in pGL-Control was actually trans activated by
LPS and PMA, whereas the P-actin promoter was relatively
unaffected (not shown).
DISCUSSION
The c-fins gene in humans is closely linked to the gene
encoding the platelet-derived growth factor (PDGF) receptor
on chromosome 5 (20). Exon 1, located less than 500 bp
downstream of the PDGF receptor gene, is transcribed only
in trophoblasts and choriocarcinomas (20, 30). In human
monocyte cell lines, transcription initiates immediately 5' of
exon 2, which contains the initiation codon. Figures 1 and 2
show that the sequences of the mouse and human c-fins
genes adjacent to exon 2 are conserved and that murine
primary macrophages and the macrophage line RAW264
produce transcripts initiated at a cluster of transcription start
sites in this region. These data are consistent with analysis of
the human c-fins gene in macrophages (20), which identified
a similar diversity of transcription start sites. The presence
of multiple clustered transcription starts is common in
TATA-less promoters (1, 26). The other element typically
involved in specifying accurate transcription initiation is the
CCAAT box, which is usually placed 50 to 90 bp upstream of
the transcription start site (6). The repeated CCAAT-like
motif around 60 to 100 bp from the multiple transcription
start sites of c-fins, although it does not fit the CCAAT box
consensus sequences, does bind multiple DNA-binding pro-
teins in all cell lines tested, including at least one nuclear
protein that also binds the CCAAT box sequence of the
ubiquitously active H2-K promoter (unpublished data).
Taken together, the transient transfection and reverse
transcriptase primer extension analyses in Fig. 2, 3, 5, 7, 8,
and 9 suggest that expression of full-length c-fins mRNA in
macrophages is controlled primarily by sequences in intron 2
that probably mediate tissue-specific transcription elonga-
tion. This conclusion contrasts with the claim that the
homologous human c-fins promoter directs monocyte-spe-
cific expression of a CAT reporter gene in transient trans-
fection analysis (20). Given the substantial homology be-
tween the promoters from the two species (Fig. 1) and the
conserved patterns of expression, it seems unlikely that this
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contrast reflects a genuine species difference. One possibility
is that the SV40 enhancer included at the 3' end of the CAT
gene in the human c-fins reporter constructs (20) confers
tissue specificity as well as detectability. This possibility is
favored by the data in Fig. 9A, which suggest that the SV40
promoter plasmid is tissue specific. An alternative view of
the regulation of c-fins during human monocyte/macrophage
differentiation derives from the work of Weber et al. (32),
who suggested that the gene is controlled via differential
mRNA stability. The primer extension data do not com-
pletely exclude this as an explanation for tissue specificity
and the actions of LPS, PMA, and CSF-1 but argue strongly
against it. c-fins transcripts were detected in nonmacro-
phages with exon 2 primers (A and B) and the intronic primer
(F) but not with the exon 3 primer (E). Primers B and E are
contiguous in the spliced c-fins mRNA, and it is difficult to
envisage a degradative pathway that spares the 5' end of
c-fins so rigorously. In nuclear run-on transcription assays
using a full-length cDNA, we could not detect c-fins tran-
scripts in L929 or MOPC.31C cells, whereas they were of
comparable abundance to P-actin transcripts in RAW264
cells (data not shown). Furthermore, Gusella et al. (11)
provided clear evidence that the down-regulation of c-fins in
a murine macrophage line by LPS occurred at the level of
transcript synthesis rather than mRNA stability. Hence, we
strongly favor controlled transcription elongation as the
explanation of the apparent presence of short c-fins tran-
scripts in nonmacrophages and macrophages treated with
LPS, PMA, and CSF-1.
Control of gene expression by at the level transcription
elongation has been observed in many cellular genes, includ-
ing the adenosine deaminase, c-myc, c-myb, c-fos, and
epidermal growth factor receptor (EGF-R) genes (see refer-
ences 4, 7, 12, 19, and 27 and references therein). The
EGF-R is particularly interesting since it is another member
of the protein tyrosine kinase family of receptors and directs
tissue-specific differentiation of a number of epithelial cell
lineages. The EGF-R gene, like c-fins, is expressed from a
TATA-less promoter and initiates from multiple clustered
sites (12). Promoter activity does not correlate with patterns
of expression, and a major determinant of full-length mRNA
production is a transcription termination site in the first
intron. As with this and most other examples of transcription
attenuation, we have not been able to define exactly where
the attenuated transcripts end in the case of c-fins. Although
the primer extension data (Fig. 2 and 3) and dot blot
hybridization (Fig. 6B) indicate that short transcripts are as
abundant in nonmacrophages as is the full-length mRNA in
macrophages, they could not be detected by Northern blot-
ting with a cDNA or a genomic DNA probe (not shown), and
no bands protected from SI nuclease were detected in
nonmacrophages in the published studies of the human c-fins
gene (20, 30). Similarly, we could not detect the short
transcripts in nonmacrophages by RNase protection (Fig.
6A). In every case in which the 3' ends of attenuated
transcripts have been identified, they are extremely hetero-
geneous (27) even when analyzed in cell-free transcription
assays (16). Since the 5' ends of the c-fins transcripts are also
heterogeneous, part of the reason they cannot be detected in
Northern blots or nuclease protection may be that they do
not form a definable band on a gel. An additional problem
influencing detection of the short transcripts by nuclease
protection is the abundance of extended GC-rich inverted
repeats in exon 2 and the beginning of intron 2. In fact, the
mouse sequence from -70 to +110 contains 63% GC resi-
dues. GC-rich stem-loops in both DNA and RNA are re-
markably stable (13). Furthermore, there is the potential for
interchain hybridization between short c-fins transcripts
because of the inverted repeats. The existence of duplexes
and stem-loops in short c-fins transcripts would probably
reduce hybridization in nuclease protection assays, and any
regions of mismatch or loop formation would not be pro-
tected from cleavage.
Those attenuators that have been characterized in pro-
karyotic and eukaryotic systems often contain GC-rich mo-
tifs with dyad symmetry (27). The c-fins sequences in exon
2, early in intron 2 (Fig. 4), and in exon 3 (mouse cDNA bp
127 to 139; 5'-CAGGGGGCCCCTG-3') clearly resemble
other attenuator sequences, including those of the c-fos gene
(5'-TCCCCGGCCGGGGA-3') (18), the c-myb gene (5'-GC
CCCCTGTGGGC-3') (19), and the TAR region of human
immunodeficiency virus type 1 (as shown in Fig. 4). Homol-
ogies between c-fins sequences and the c-fos and c-myb
terminators may be of functional significance. The c-fos
attenuator is apparently involved in the regulation of c-fos
transcription elongation in macrophages (7). c-myb is ex-
pressed in myeloid progenitor cells, and transcriptional
elongation is down-regulated during myeloid differentiation
(19). There might conceivably be a link between the control
of transcription elongation of c-myb and c-Jins.
In summary, we have provided evidence that tissue-
specific expression of the murine c-fins gene in macrophages
and its regulation by specific agonists involve sequences in
intron 2 that probably control transcription elongation. Be-
cause c-fins is the receptor for the major macrophage growth
and differentiation factor CSF-1, selective elongation of
c-fins transcripts may be viewed as the rate-limiting event in
macrophage differentiation.
REFERENCES
1. Blake, M., R. Jambou, A. Swick, J. Kahn, and J. Azikhan. 1990.
Transcription initiation is controlled by upstream GC-box inter-
actions in a TATAA-less promoter. Mol. Cell. Biol. 10:6632-
6641.
2. Bonnifer, C., M. Vidal, F. Grosveld, and A. Sippel. 1990.
Tissue-specific and position independent expression of the com-
plete gene for chicken lysozyme in transgenic mice. EMBO J.
9:2835-2842.
3. Cassady, A. I., K. J. Stacey, K. A. Nimmo, K. M. Murphy, D.
vonderAhe, D. Pearson, F. M. Botteri, Y. Nagamine, and D. A.
Hume. 1991. Constitutive expression of the urokinase plasmin-
ogen activator gene in RAW264 macrophages involves distal
and 5' non-coding sequences that are conserved between mouse
and pig. Nucleic Acids Res. 19:6839-6847.
4. Chen, Z., J. W. Innis, M. Sun, D. A. Wright, and R. E. Kellems.
1991. Sequence requirements for transcriptional arrest in exon 1
of the human adenosine deaminase gene. Mol. Cell. Biol.
11:6248-6256.
5. Chiu, R., M. Imagawa, R. Imbra, J. Bockoven, and M. Karin.
1987. Multiple cis- and trans-acting elements mediate the tran-
scriptional response to phorbol esters. Nature (London) 329:
648-651.
6. Chodosh, L., A. Baldwin, R. Carthew, and P. Sharp. 1988.
Human CCAAT-binding proteins have heterologous subunits.
Cell 53:11-24.
7. Collart, M., N. Tourkine, D. Belin, P. Vassill, P. Jeanteur, and
J.-M. Blanchard. 1991. c-fos gene transcription in murine mac-
rophages is modulated by a calcium-dependent block to elonga-
tion in intron 1. Mol. Cell. Biol. 11:2826-2831.
8. Evans, R., S. J. Kamdar, and T. M. Duffy. 1991. Tumor-derived
products induce IL-la, IL-1,, TNF-a and IL-6 gene expression
in murine macrophages. Distinctions between tumor induced
and bacterial endotoxin-induced gene expression. J. Leukocyte
Biol. 49:474-482.
9. Gisselbrecht, S., S. Fichelson, B. Sola, D. Bordereaux, A.
Hampe, C. Andre, F. Galibert, and P. Tambourin. 1987. Fre-
MOL. CIELL. BIOL.
c-fins GENE REGULATION 3201
quent c-fns activation by proviral insertion in mouse myeloblas-
tic leukaemias. Nature 329:259-261.
10. Grewal, T., M. Theisen, U. Borgmeyer, T. Grussenmeyer, R.
Rupp, A. Stief, F. Qian, A. Hecht, and A. Sippel. 1992. The
-6.1-kilobase chicken lysozyme enhancer is a multifactorial
complex containing several cell-type-specific elements. Mol.
Cell. Biol. 12:2339-2350.
11. Gusella, G., E. Ayroldi, I. Espinoza-Delgado, and L. Varesio.
1990. Lipopolysaccharide, but not IFN-y, down-regulates c-fms
mRNA protooncogene expression in murine macrophages. J.
Immunol. 144:3574-3580.
12. Haley, J. D., and M. D. Waterfield. 1991. Contributory effects of
de novo transcription and premature transcript termination in
the regulation of human epidermal growth factor receptor pro-
tooncogene RNA synthesis. J. Biol. Chem. 266:1746-1753.
13. Hirao, I., Y. Nishimura, Y.-I. Tagawa, K. Watanabe, and K.-I.
Miura. 1992. Extraordinarily stable mini-hairpins: electro-
phoretical and thermal properties of the various sequence
variants of d(GCGAAGC) and their effect on DNA sequencing.
Nucleic Acids Res. 20:3891-3896.
14. Hume, D. A., and Y. Denkins. 1989. Activation of macrophages
to express cytocidal activity correlates with inhibition of their
responsiveness to macrophage colony-stimulating factor (CSF-
1): involvement of a pertussis toxin-sensitive reaction. Immu-
nol. Cell Biol. 67:243-249.
15. Hume, D. A., and R. Nayar. 1989. Encapsulation is not involved
in the activities of recombinant gamma interferon associated
with multilamellar phospholipid liposomes on murine bone
marrow-derived macrophages. Lymphokine Res. 8:415-427.
16. Innis, J. W., and R. E. Kellems. 1991. A heat-labile factor
promotes premature 3' end formation in exon 1 of the murine
adenosine deaminase gene in a cell-free transcription system.
Mol. Cell. Biol. 11:5398-5409.
17. Klemsz, M., S. McKercher, A. Celada, C. vanBeveren, and R.
Maki. 1990. The macrophage and B cell-specific transcription
factor PU.1 is related to the ets oncogene. Cell 61:113-124.
18. Lamb, N., A. Fernandez, N. Tourkine, P. Jeanteur, and J.-M.
Blanchard. 1990. Demonstration in living cells of an intragenic
negative regulatory element within the rodent c-fos gene. Cell
61:485-496.
19. Reddy, C., and E. Reddy. 1989. Differential binding of nuclear
factors to the intron 1 sequences containing the transcriptional
pause site correlates with c-myb expression. Proc. Natl. Acad.
Sci. USA 86:7326-7330.
20. Roberts, W., L. Shapiro, R. Ashmun, and A. Look. 1992.
Transcription of the human colony-stimulating factor-1 receptor
gene is regulated by separate tissue-specific promoters. Blood
79:586-593.
21. Rothwell, V. M., and L. R. Rohrschneider. 1987. Murine c-fins
cDNA: cloning, sequence analysis and retroviral expression.
Oncogene Res. 1:311-324.
22. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular
cloning: a laboratory manual. Cold Spring Harbor Laboratory
Press, Cold Spring Harbor, N.Y.
23. Sariban, E., K. Imamura, M. Sherman, V. Rothwell, P. Pantazis,
and D. Kufe. 1989. Downregulation of c-fins gene expression in
human monocytes treated with phorbol esters and colony-
stimulating factor 1. Blood 74:123-129.
24. Sherr, C. J. 1990. Colony-stimulating factor-1 receptor. Blood
75:1-12.
25. Skalnik, D., D. Dorfman, A. Perkins, N. Jenkins, N. Copeland,
and S. Orkin. 1991. Targetting of transgene expression to
monocyte-macrophages by the gp9l-phox promoter and conse-
quent histiocytic malignancies. Proc. Natl. Acad. Sci. USA
88:8505-8509.
26. Smale, S., and D. Baltimore. 1989. The "initiator" as a tran-
scriptional control element. Cell 57:103-113.
27. Spencer, C., and M. Groudine. 1990. Transcription elongation
and eukaryotic gene regulation. Oncogene 5:777-785.
27a.Stacey, K. J., and D. A. Hume. Unpublished data.
28. Stacey, K. J., I. L. Ross, and D. A. Hume. Electroporation and
DNA-dependent cell death in murine macrophages. Immunol.
Cell Biol., in press.
29. Stanley, E. R. 1986. Action of colony-stimulating factor (CSF-
1). CIBA Found. Symp. 118:29-41.
30. Visvader, J., and I. M. Verma. 1989. Differential transcription of
exon 1 of the human c-fns gene in placental trophoblasts and
monocytes. Mol. Cell. Biol. 9:1336-1341.
31. Wasylyk, B., C. Wasylyk, P. Flores, A. Begue, D. Leprince, and
D. Stehelin. 1990. The c-ets protooncogenes encode transcrip-
tion factors that cooperate with c-Fos and c-Jun for transcrip-
tion activation. Nature (London) 346:191-194.
32. Weber, B., J. Horiguchi, R. Luebbers, M. Sherman, and D.
Kufe. 1989. Posttranscriptional stabilization of c-fins mRNA by
a labile protein during human monocytic differentiation. Mol.
Cell. Biol. 9:769-775.
VOL. 13, 1993
